The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Kaeren, I take it that he is referring to the Eastleigh and Camberley sites and possibly the Stratford upon Avon and Blizzard clinical trials sites. Greater than 30 in-house and external ivd studies completed since he took on the role at the beginning of the year . That's a 50% increase from what was mentioned in the August investor presentation.
Why again is DA to update us? 10 days an RNS up 30% and still bemoaned. If that 30% was held and we were at late 400s would it matter, no it wouldnt.
The perspective here is garbage. Yes NCYT are a tad light on the comms, but this nonsense over sending out RNS to stop a share price tumble is not the solution.
A helpful post above shows the market has beefed up on covid stocks 7-10days ago, is clearly reacting to another period of unstableness ahead with a media circus.
For me NCYT as a prominent PCR supplier will highly likely have a good strategy in place across many disciplines to service and aid the testing plight. I just do not get this constant whine over DA to do this, say hello and such like. How about promote and drive on the business to midcap as suggested previously?
Not even going to mention the resolution with DHSC!
Doesnt he use Trevor?
Sorry yes I understand Exmex I was asking about the 4 sites and 70 staff.
Ajan Reginald
Ah yes ok to the ok post which I missed totally.
4 ?
Kaeren, I was referring the information there that gives an insight into his original role at Novacyt and what he has been doing in his current position.
I also noticed that Immune Express finally received FDA clearance for their Septicyte rapid sepsis test last week .
https://www.prnewswire.com/news-releases/fda-clears-septicyte-rapid--the-first-one-hour-direct-from-blood-sepsis-test-301434065.html
Considering the high profile appointments to senior sales positions within Novacyt, to me suggests exciting new products that are soon to be launched. The company would not be making such appointments unless they had something to sell globally!!
@DRB3
Maybe the reason for the delay is for the very reason you suggested in your last message.
A credible strategy would need to be comprehensive and take all issues into account ( not like the numerous Mickey Mouse plans and U-turns we've all become accustomed to over the last few years).
Well, if we don't get a strategy update by Friday this week I will be the first to say I got it wrong. Still hopeful. After all, other than the CTDA updates, we haven't had any substantial news since 30th Sept. Almost 10 weeks.
Agree 100% Uggy.
I agree troublesome. But we´re still an AIM stock & therefore prone to gyrations in sp. What we want is updates on progress which we don´t get. The BOD must know this & still remain reluctant to update us. Have to say that they´ve been pretty shabby of late. DA still remains anonymous to his shareholders. Sure., I hope he´s busy but surely not so busy that he can´t engage with us.
As far as I'm aware this company is still selling its wide range of products to 140+ countries worldwide so wouldn't expect any kind of reduction in demand given the present situation and the increased need for PCR tests.
Novacyt prides itself on the quality of its innovative products and equally importantly, their sustainability.
Don't think any of these factors has changed ??
It's like the tube "Mind the gap "
Has AJ updated his experience details on LinkedIn or did I miss last time I looked.
Katalyst rolling along Tks to Kilkenny ted I presume it's not on yet
https://twitter.com/KilkennyTed/status/1467910057300008960
Well if the current management team cannot organise selling £millions of PCR tests in the middle of this Covid 19 pandemic, especially with the new Omicron variant on the march, and all the new travel restriction and testing requirements in place around the world, they need to be collectivy sacked! I either expect an RNS saying PCR sales are through the roof or they have all been sacked/resigned.
The omicron is a trade dream for the global institutions, banks and governments. What will tomorrow be, risk off? Who knows ……global manipulation stirred up by the worlds media and funded by those financial manipulators.
Bluelight, it's futile to make a prediction because I don't have any clue which way the market will go tomorrow. Same as many on here. Apologies for calling you out in particular, there's quite a few at it and it's become tiresome.
In fact don't bother responding as I've just green binned you. You whinge more than an old woman, waste of my time reading your snide little comments
Don't forget that the nasdaq has suffered the worst start in December for 20 years... so markets aren't exactly sweet.
People are jittery and if they can bank 10% gains on a swinger like ncyt, then that's awesome for them.
Meanwhile lth's wait, as value will out in the end... let's just hope this happens before markets completely melt and catastrophe ensues!
this is one of those days that has nothing to do with Novacyt. Every covid related stock is red apart from the GDR pump and dump. Plus a load more others not shown below!
BioNTech -15.81
Moderna -14.26
BioNTech -13.9
Moderna -13.87
Myhealthchecked -10.2
Valneva -8.81
Catenae Innovation -6.96
Avacta Group -6.25
Evgen Pharma PLC -6.14
Omega -5.66
Valirx -5.07
Open Orphan -4.76
GSTechnologies -4.22
Synairgen -4.18
Novacyt -4.17
Abingdon Health -4.17
Biosynex -4.15
Yourgene Health -4.08
Pfizer -3.88
Genomicvision -3.75
Oxford Nanopore Tech -3.58
Deepverge -3.09
Oxford BioMedica -3.02
Thermo Fisher Scientific -3
Sensyne Health -2.78
Eurobio Scientific -2.72
Pfizer -2.47
Novacyt -2.33
Inovio -2.23
Braveheart -2
Chembio -1.7
Nuformix -1.67
Batm -1.52
Amryt Pharma -1.38
NetScientific -1.38
Abcam -1.14
EKF Diagnostics -0.66
Avantor -0.63
Sourcebio 0
Hemogenyx Pharma 0
Fusion Antibodies 0
Vela Technologies 0
Your point is Johnny? You seem to love calling me out on every prediction. Why don't you man up and make your own prediction instead of *****ing about mine. Good to have your own opinion buddy, no one likes a hindsight analyst of peoples predictions, it's tetchy.
The problem with the share and why investors remain unhappy is that its performance does not reward long term investors (yet). Only one who profits here is swing traders. The emphasis on having to retrace every rise to fill a gap is case in point. Its trading behaviour ignores fundamentals and focuses pretty much exclusively on charts. That won't last of course, fundamentals always shine through. It is however pretty galling to long term investors who have backed the right horse but haven't as yet seen the rewards their patience and call deserves.
Bluelight, I hope you've given your crystal ball a clean for tomorrows prediction. Because your calls on the trajorty so far have been a little off, being kind there.